 (See Tyrosine-kinase inhibitor )

Cancer's response to an inhibitor of tyrosine kinase was assessed in a clinical trial.In this case, Gefitinib is the inhibitor of tyrosine kinase.Incorrect tyrosine kinase function can lead to non-small cell lung cancer.